Dana Shkolny

Dana Shkolny is a highly experienced professional who has held various roles in project management, program management, and business development within the pharmaceutical and biotechnology industry. Currently serving as the Chief of Staff to the CEO at Candel Therapeutics, Dana has also worked at Takeda in different capacities, overseeing strategic operations, program management, and leading teams in drug development. With a background in genetics and biology, Dana has a diverse skill set that has been instrumental in supporting high-performing teams and contributing to the success of various projects and initiatives throughout their career.